OpenAI to Preview GPT-6 Cyber AI Model for Cybersecurity 
Dollar Holds Near Two-Month High as Yen Approaches 160 
Asian Currencies Mixed as Dollar Holds Near Two-Month High 
Meta Found Liable in New Mexico Facebook Data Privacy Case 
China’s ‘Lipstick King’ Says AI Won’t Replace Livestream Hosts 
Tesla Semi Rollout Begins at Nevada Factory 
AMD Hits $1 Trillion as BofA Raises Price Target to $720 
Gold Holds Near $4,275 as Rising Treasury Yields Fuel Fed Rate Hike Bets 
Airbus Finds A321neo Fuselage Quality Issue 
EQT Plans €1.7 Billion Sale of Parques Reunidos Stake 
DaVoice Sues Perplexity AI Over Trade Secrets 
US Backs Musk in Fight Against EU’s €120 Million X Fine 
Fed’s Hammack Says Bond Yield Surge Is Not Driven by Inflation Fears 
Asian Stocks Fall as Surging Bond Yields Rattle Markets 
Australia Unemployment Hits Five-Year High Despite Strong Jobs Growth 
US Appeals Court Upholds Anthropic AI Supply Chain Ban 
Oracle Shares Fall as New Mexico AI Data Center Faces Power Delays 
Add as a preferred source on Google
GSK Consumer Healthcare Korea was revealed to have appointed a new chief executive officer, and it was revealed to be Shin Dong Woo, a former CEO of the company’s branch in Hong Kong.
According to The Korea Times, GSK Consumer Healthcare Korea announced the assignment of CEO Shin earlier this week. It was reported that the new chief has been with the company for 28 years and has led GSK in various international businesses - from consumer health care to general consumer goods.
He also led other health care firms such as Pfizer and Sanofi. Prior to his assignment as the new chief at GSK Consumer Healthcare Korea, he has been leading the Honk Kong unit for the last two years. During his tenure, he has many achievements, including boosting the business and building the foundation for its stability.
At Sanofi Korea, he became the first president of the He also completed the company's integration with Pfizer Consumer Healthcare, where he was CEO of the Korean branch and the Asia-Pacific region between 2015 and 2020.
Shin also became the very first president of the French multinational healthcare company’s Korean unit. He helped established the brand in the country and introduced major products that are now selling very well here., and this is not all. Shin has extensive experience in marketing as well as he worked at Coca-Cola, L’Oreal, and Fox Home Entertainment and was in charge of marketing and sales for more than a decade.
Meanwhile, Shin will lead GSK Consumer Healthcare Korea, which has recently changed its name to Haleon. This will be the company’s official name as it starts its consumer healthcare venture. The name means the company will also change all of its product packaging.
"With the announcement of 'Haleon' today, we are one step closer to our goal of becoming a consumer healthcare company,” Haleon’s CEO-nominee, Brian McNamara, said in a press release in February. “'Haleon' will stand as a leader in the consumer healthcare industry with the vision of delivering better daily health to mankind.”
“Haleon” is the outcome of the successful merging of Novartis in 2015 and Pfizer's consumer healthcare portfolio in 2019 over the past eight years.
